Lassen Therapeutics Website, Blog & Press Pages

Lassen Therapeutics Website, Blog & Press Pages - aVenture

Lassen Therapeutics - Library

lassentherapeutics.comCrawled Oct 15, 2026

Press

5 pages

Lassen Therapeutics Announces Collaboration with Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis/news/lassen-therapeutics-announces-collaboration-with-cedars-sinai-medical-center-to-study-the-role-of-il-11-signaling-and-inhibition-in-preclinical-models-of-lung-fibrosis
Goal is to generate proof of principle and mechanistic understanding of the efficacy of antibodies targeting IL-11 receptor in idiopathic pulmonary fibrosis
Lassen Therapeutics Announces Collaboration with the Olivia Newton-John Cancer Research Institute to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Breast Cancer/news/lassen-therapeutics-announces-collaboration-with-the-olivia-newton-john-cancer-research-institute-to-study-the-role-of-il-11-signaling-and-inhibition-in-preclinical-models-of-breast-cancer
Lassen Therapeutics a biotechnology company developing antibodies as potential treatments for fibrosis and oncology, today announced a collaboration with the Olivia Newton-John Cancer Research Institute (ONJCRI) in Melbourne, Australia.
Lassen Therapeutics Announces Formation of Scientific Advisory Board/news/lassen-therapeutics-announces-formation-of-scientific-advisory-board
Lassen Therapeutics announced the formation of its scientific advisory board.
Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology/news/lassen-therapeutics-launches-to-discover-and-develop-novel-antibody-therapeutics-including-lead-program-targeting-il-11-to-treat-fibrosis-and-oncology
Lassen Therapeutics secured $31 million in Series A financing to develop antibodies as potential treatments for fibrosis, rare diseases, and oncology. Frazier Healthcare Partners led the round, with Alta Partners and Longwood Fund participating.

Careers & Hiring

2 pages

Careers/careers
The company aims to improve lives and provide hope to patients facing difficult diseases and seeks ambitious, inspired team members.
Lassen Therapeutics Announces Presentations on Novel IL-11 Receptor-Blocking Antibody at the American Thoracic Society 2022 Annual Meeting/news/lassen-therapeutics-announces-presentations-on-novel-il-11-receptor-blocking-antibody-at-the-american-thoracic-society-2022-annual-meeting
Lassen selected for oral presentation at ATS scientific sessions and will be featured at the ATS Respiratory Innovation Summit

Team

6 pages

Andrew Nash, PhD/team/andrew-nash-phd
Andrew Nash, Ph.D. is the Chief Scientific Officer of CSL Limited, a leading global biotechnology company with a portfolio of life-saving medicines and vaccines.
Christoph Westphal, MD, PhD/team/christoph-westphal-md-phd
Christoph Westphal, MD, PhD, is co-founder and general partner of Longwood Fund and has 20 years of experience as a life sciences CEO, entrepreneur, and investor. Companies he founded developed drugs that received FDA approval.
Cory Hogaboam, PhD/team/cory-hogaboam-phd
Cory Hogaboam, Ph.D. is Professor of Medicine and Research Scientist in the Women's Guild Lung Institute in the Department of Medicine at Cedars-Sinai and Adjunct Professor of Pathology at the University of Michigan.
David King, PhD/team/david-king
David King, Ph.D., is co-founder and CSO of Lassen. David King served as CSO of aTyr Pharma, where David King developed therapeutics based on tRNA synthetase biology, and as CSO of AnaptysBio.

About

4 pages

About/about
Leadership/about/leadership
Proven track record of building robust antibody development platforms and pipelines
Our Approach/about/our-approach
Developing a pipeline of biotherapeutics against compelling new targets that are central to diseases with significant unmet needs.
Scientific Advisory Board/about/scientific-advisory-board

Contact

1 page

Contact/contact
Contact Lassen Therapeutics in San Diego, CA

Homepage

1 page

Homepage/
Lassen Therapeutics is developing biotherapeutics for serious diseases, with the aim of improving patients' lives.